BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...gene expression levels without cutting DNA or RNA. Participating in the round were new investor UTokyo Innovation Platform...
BioCentury | Feb 17, 2017
Finance

Tokyo connection

...firm’s Remiges BioPharma Fund L.P. came on Feb. 14 with a $10 million investment from UTokyo Innovation Platform...
BioCentury | Feb 14, 2017
Financial News

Remiges tops off $80M biotech fund

...close of Remiges BioPharma Fund L.P., bringing the fund's total to $80 million. New LP UTokyo Innovation Platform...
Items per page:
1 - 3 of 3
BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...gene expression levels without cutting DNA or RNA. Participating in the round were new investor UTokyo Innovation Platform...
BioCentury | Feb 17, 2017
Finance

Tokyo connection

...firm’s Remiges BioPharma Fund L.P. came on Feb. 14 with a $10 million investment from UTokyo Innovation Platform...
BioCentury | Feb 14, 2017
Financial News

Remiges tops off $80M biotech fund

...close of Remiges BioPharma Fund L.P., bringing the fund's total to $80 million. New LP UTokyo Innovation Platform...
Items per page:
1 - 3 of 3